Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia

Wei Liu1, John D Clemens, Komang Kari

  • 1International Vaccine Institute, San 4-8, Bongcheon-7 dong, Kwanak-ku, Seoul 151-818, Republic of Korea.

Vaccine
|July 8, 2008
PubMed

Insights

A live, attenuated Japanese encephalitis (JE) vaccine program in Bali could prevent 54 cases and 5 deaths over 11 years. This immunization strategy is highly cost-effective, saving disability-adjusted life years (DALYs) at a low cost per case and DALY averted.

Area of Science:

  • Epidemiology
  • Public Health
  • Vaccinology

Background:

  • Japanese encephalitis (JE) poses a significant public health risk, particularly in endemic regions like Bali.
  • Understanding the economic impact and effectiveness of vaccination programs is crucial for disease control.

Purpose of the Study:

  • To model the cost-effectiveness of a live, attenuated JE vaccine immunization program in Bali.
  • To estimate the potential impact of JE vaccination on disease incidence, mortality, and disability-adjusted life years (DALYs).

Main Methods:

  • A hypothetical birth cohort of 100,000 newborns in Bali was modeled over 11 years.
  • JE risk was estimated using cumulative incidence data from before vaccine introduction.
  • Data on vaccine efficacy, vaccination, and treatment costs were sourced from published literature and surveys.

Main Results:

  • The modeled immunization program averted an estimated 54 JE cases and 5 deaths.
  • The program saved 1,224 disability-adjusted life years (DALYs).
  • The net cost was USD 700 per JE case averted and USD 31 per DALY saved.

Conclusions:

  • The live, attenuated JE vaccine program is a highly cost-effective intervention for preventing Japanese encephalitis in Bali.
  • Vaccination significantly reduces disease burden, mortality, and disability, offering substantial public health benefits.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...